These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7610837)

  • 61. Effects of the polyacetylene capillin on human tumour cell lines.
    Whelan LC; Ryan MF
    Anticancer Res; 2004; 24(4):2281-6. PubMed ID: 15330173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Taxol as a radiation sensitizer: a flow cytometric study.
    Steren A; Sevin BU; Perras J; Ramos R; Angioli R; Nguyen H; Koechli O; Averette HE
    Gynecol Oncol; 1993 Jul; 50(1):89-93. PubMed ID: 8102348
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
    Erjala K; Pulkkinen J; Kulmala J; Alanen K; Grenman R
    Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radical radiotherapy for carcinoma of the larynx in the elderly: Functional and oncological outcomes from a tertiary cancer care center in India.
    Subramaniam NR; Srinivasalu VK; Balasubramanian D; Pushpaja KU; Nair AR; Prameela C; Thankappan K; Iyer S
    Indian J Cancer; 2017; 54(3):493-497. PubMed ID: 29798945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines.
    Adler LM; Herzog TJ; Williams S; Rader JS; Mutch DG
    Cancer; 1994 Oct; 74(7):1891-8. PubMed ID: 7915965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Collision tumor of a hypopharyngeal adenoidcystic carcinoma and a laryngeal squamous cell carcinoma].
    Kufeld M; Junker K; Sudhoff H; Dazert S
    Laryngorhinootologie; 2004 Jan; 83(1):51-4. PubMed ID: 14740306
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Photodynamic therapy and the treatment of neoplastic diseases of the larynx.
    Biel MA
    Laryngoscope; 1994 Apr; 104(4):399-403. PubMed ID: 8164476
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effective analysis of non-surgical combined treatments for laryngeal organ preservation in locally advanced laryngeal carcinoma].
    Yan F; Zhang X; Ma L; Liu M; Chen N; Wang J; Wu W; Huang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):372-7. PubMed ID: 27220298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.
    Miyanaga S; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2016 Feb; 48(2):517-24. PubMed ID: 26676807
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
    Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa.
    Mason KA; Milas L; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1381-9. PubMed ID: 7635778
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Taxol in combination with acute and low dose rate irradiation.
    Minarik L; Hall EJ
    Radiother Oncol; 1994 Aug; 32(2):124-8. PubMed ID: 7972905
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study.
    Rosenthal DI; Sinard RJ; Okani O; Corak J; Kavanaugh D; Kamen B; Vuitch FM; Gazdar AF; Griener J; Frenkel EP; Carbone DP
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-67-S19-71. PubMed ID: 9427270
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
    Prasad E; Viswanathan PN; Rangad VF; Pavamani S; Ram TS
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):488-93. PubMed ID: 19386478
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Synergistic interactions of TRAIL and paclitaxel on the laryngeal squamous carcinoma cell line in vitro].
    Zhang M; Zhou L; Xie M; Tian J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1105-8. PubMed ID: 18330255
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of concurrent chemoradiation in laryngeal preservation for supraglottic cancer.
    Yoon TM; Lee JK; Cho JS; Lim SC; Chung WK
    J Otolaryngol Head Neck Surg; 2010 Apr; 39(2):142-9. PubMed ID: 20211100
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical value of NSD and CRE in the evaluation of risk of post-irradiation complications in patients with laryngeal cancer].
    Maciejewski B
    Nowotwory; 1982; 32(3):153-63. PubMed ID: 7155911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.